Tuesday, August 17, 2021 9:57:59 PM
The terminology "Exclusive Worldwide License Agreement" always sounds amazing on the surface.
However, what they have done is basically obtained the Intellectual Property from PRSTRT and St. Jude. Further to this though is that a patent application has already been submitted.
This is another item they can stair-step to human trials. But this is not yet a promise of a sale, distribution, or otherwise.
"Revive, PRSTRT and St. Jude agreed to terms consistent with industry standards, including future payments based on clinical trial and revenue milestones."
One step closer on another item, but I will still be growing and holding.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM